Fundraising Fox

Bart De Leeuw

Investor

Partner/CFO at Fund+

Belgium

About

Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.

Contact· self-published, not guessed

Experience

  1. FundPlusPartnercurrent2023 — present
  2. EyeD PharmaBoard Membercurrent2023 — presentLiege Metropolitan Area
  3. UniD ManufacturingBoard Membercurrent2023 — presentLiege Metropolitan Area
  4. Coave TherapeuticsBoard Membercurrent2023 — presentGreater Paris Metropolitan Region
  5. EPICS TherapeuticsBoard Membercurrent2024 — presentGosselies
  6. WOLLUXCEO2021 — 2023Kortrijk, Flemish Region, Belgium
  7. Koramic Visual CommunicationMember Of The Management Board2021 — 2023Mouscron, Walloon Region, Belgium
  8. Fortino Capital PartnersCFO2019 — 2020Antwerpen Berchem, Vlaanderen, België
  9. Ackermans & van HaarenFinance2016 — 2019
  10. Ernst&YoungIFRS2002 — 2016
  11. Wolters Kluwer Financial Services | FinArchBusiness Consultant2000 — 2002Greater Boston
  12. BNP Paribas FortisConsolidatie1996 — 2000

Skills & more

Financial Reporting10Financial Analysis2International Financial Reporting Standards (IFRS)Internal Controls5Finance1Financial Accounting4Accounting4Financial Audits3Management ConsultingCorporate Finance1IFRS18US GAAP2
+1 moreInternal Audit

From Bart's professional profile.

Colleagues at Fund+

Caroline Goddeeris
Partner at Fund+
Chris Buyse
Board Member at Fund+
Désiré Collen
Honorary Chairman / Board Observer at Fund+
Diane De Wyngaert
Administrative Assistant at Fund+
François Fontaine
Board Member at Fund+
Halina Novak
Principal at Fund+
Kenneth Bonheure
Board Member at Fund+
Luc Debruyne
Chairman of the Board at Fund+

Frequently asked questions

Who is Bart De Leeuw?
Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.
Where does Bart De Leeuw work?
Bart De Leeuw is Partner/CFO at Fund+.
Where did Bart De Leeuw go to school?
Bart De Leeuw studied at HUB-KUBrussel.

Same school

Also attended HUB-KUBrussel1

Ludovica TartaglioneInnovation & Corporate Venturing Manager at LVenture Group

Shared employers

Also worked at EyeD Pharma4

Sofie BaetenManaging Partner at Qbic FundHalina NovakPrincipal at Fund+Frédéric SchyntsInvestment Manager at Meusinvest (Noshaq)Chris BuyseBoard Member at Fund+

Also worked at Coave Therapeutics1

Willem BroekaertManaging Partner at V-Bio Ventures

Also worked at Ernst&Young1,168

Tyler WilsonSenior Accountant at Felicis VenturesSandra SchwarzerInvestor at Index VenturesLinn Hege AuneInvestor at InvestinorTorjusInvestor at InvestinorAngela ToyPartner & COO at Golden Gate VenturesMahesha SubramaniamHead of Client Relations at Golden Gate Ventures

+ 1,162 more

Also worked at BNP Paribas Fortis27

Jane MacDonaldExecutive Assistant at Iris CapitalRoel BulthuisInvestor at SynconaPedro del PozoBoard Member at Axon Partners GroupHiram ClausInvestment Director at NPM Capital N.V.Harry HaeckPartner at SmartFinJimmy FrischlingFounder and Managing Partner at Branded Strategic Hospitality

+ 21 more